FIASP

Novo Nordisk Canada Inc🇨🇦 Health Canada

Approval Id: e1a82825c2be315f
Drug Approval Canada Name: FIASP
Product Name: FIASP
Status: Marketed
Status Date: 2017-03-03
Original Market Date: 2017-03-03
Din: 02460416
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous
Schedule: Schedule D
Ahfs: 68:20.08
Atc Original: A10AB05 INSULIN ASPART
Atc Name: a 10 ab 05
Aig Number: 0144802001
Company Name: Novo Nordisk Canada Inc
Company Address: 101-2476 Argentia Road, Mississauga, Ontario, Canada, L5N 6M1

INSULIN ASPART

100 UNIT / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

e1a82825c2be315f

Type

Standard